Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (111-120 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayJeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
Clinical Nuclear Medicine|March 26, 2014
Differentiation of an unclear splenic lesion in a patient with cholangiocarcinomaConstantin Lapa, Ulrich Steger, Christian O Ritter, et al.
Clinical Nuclear Medicine|August 19, 2015
Localization of Parathyroid Adenoma With Real-Time Ultrasound: Freehand SPECT FusionChristina Bluemel, Paul Kirchner, Georg W Kajdi, et al.
Nuclear Medicine Communications|March 9, 2018
Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activitiesMarcus Ruhlmann, Wilfried Sonnenschein, James Nagarajah, et al.
Deutsches Arzteblatt International|February 15, 2023
Personalized Treatment for Patients With Lung CancerMartin Schuler, Servet Bölükbas, Kaid Darwiche, et al.
Nuklearmedizin. Nuclear Medicine|August 25, 2021
[Oldies (but Goldies): Peritoneal Scintigraphy in Chronic Peritoneal Dialysis Patients]Christoph Berliner, Kristina Boss, Anke Pape, et al.
European Urology|October 24, 2022
More Accurate Imaging Is Not Stage Migration: Time To Move from "Hubble" to "Webb" in Hormone-sensitive Prostate CancerNarjess Ayati, Ken Herrmann, Stefano Fanti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2022
Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PETDaniela E Oprea-Lager, Francesco Ceci, Matthias Eiber, et al.
Nature Reviews. Clinical Oncology|June 21, 2022
Radiotheranostics in oncology: current challenges and emerging opportunitiesLisa Bodei, Ken Herrmann, Heiko Schöder, et al.
Journal of Clinical Medicine|July 24, 2021
Fabry Cardiomyopathy: Current Treatment and Future OptionsIrfan Vardarli, Manuel Weber, Christoph Rischpler, et al.
Pageof 73

Showing results (111-120 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayJeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
Clinical Nuclear Medicine|March 26, 2014
Differentiation of an unclear splenic lesion in a patient with cholangiocarcinomaConstantin Lapa, Ulrich Steger, Christian O Ritter, et al.
Clinical Nuclear Medicine|August 19, 2015
Localization of Parathyroid Adenoma With Real-Time Ultrasound: Freehand SPECT FusionChristina Bluemel, Paul Kirchner, Georg W Kajdi, et al.
Nuclear Medicine Communications|March 9, 2018
Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activitiesMarcus Ruhlmann, Wilfried Sonnenschein, James Nagarajah, et al.
Deutsches Arzteblatt International|February 15, 2023
Personalized Treatment for Patients With Lung CancerMartin Schuler, Servet Bölükbas, Kaid Darwiche, et al.
Nuklearmedizin. Nuclear Medicine|August 25, 2021
[Oldies (but Goldies): Peritoneal Scintigraphy in Chronic Peritoneal Dialysis Patients]Christoph Berliner, Kristina Boss, Anke Pape, et al.
European Urology|October 24, 2022
More Accurate Imaging Is Not Stage Migration: Time To Move from "Hubble" to "Webb" in Hormone-sensitive Prostate CancerNarjess Ayati, Ken Herrmann, Stefano Fanti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2022
Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PETDaniela E Oprea-Lager, Francesco Ceci, Matthias Eiber, et al.
Nature Reviews. Clinical Oncology|June 21, 2022
Radiotheranostics in oncology: current challenges and emerging opportunitiesLisa Bodei, Ken Herrmann, Heiko Schöder, et al.
Journal of Clinical Medicine|July 24, 2021
Fabry Cardiomyopathy: Current Treatment and Future OptionsIrfan Vardarli, Manuel Weber, Christoph Rischpler, et al.
Pageof 73